Oryn Therapeutics, Inc.

Redwood City, CA

UEI
STTZK8ZF37W4
CAGE
72MC9
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
303 Twin Dolphin Dr 600 1320, Redwood City, CA 94065, USA
Website
oryntherapeutics.com
Founded
2008
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Cyclic orynotides for systemic MDR candidiasis R44AI142959 National Institute of Allergy and Infectious Diseases (NIH) $6,224,959
First-in-class macrocyclic peptide therapeutic for rheumatoid arthritis R44AR068833 National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH) $1,495,283

Quick answers

Is Oryn Therapeutics, Inc. registered in SAM.gov?

Yes. Oryn Therapeutics, Inc.'s SAM.gov registration is active through December 30, 2026.

What is Oryn Therapeutics, Inc.'s most recent federal award?

Oryn Therapeutics, Inc.'s most recent federal grant award is Cyclic orynotides for systemic MDR candidiasis (R44AI142959), from National Institute of Allergy and Infectious Diseases (NIH), on May 7, 2019.

On GovTribe

See Oryn Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login